Clinical Research Directory
Browse clinical research sites, groups, and studies.
Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUD
Sponsor: University of Vermont
Summary
Among individuals with opioid use disorder (OUD), posttraumatic stress disorder (PTSD) presents a significant clinical challenge. The prevalence of PTSD is substantially higher in individuals with OUD than in the general population, with nearly 90% reporting lifetime trauma exposure and 33% meeting diagnostic criteria for PTSD. The primary objective of this study is to evaluate the efficacy of a novel telemedicine-delivered prolonged exposure therapy protocol for improving PE attendance and reducing PTSD symptom severity in individuals with concurrent PTSD and OUD.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
135
Start Date
2024-06-03
Completion Date
2027-11-30
Last Updated
2025-04-13
Healthy Volunteers
No
Interventions
Prolonged exposure therapy
Twelve weekly 60-minute telemedicine-delivered prolonged exposure therapy sessions provided by therapists trained in prolonged exposure therapy.
Financial incentives
Financial incentives contingent upon completion of prolonged exposure therapy sessions
Treatment as usual
Continued standard buprenorphine or methadone maintenance treatment from current treatment provider.
Locations (1)
University of Vemont
Burlington, Vermont, United States